CONSULTING AGREEMENTConsulting Agreement • March 25th, 2024 • Finch Therapeutics Group, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledMarch 25th, 2024 Company Industry JurisdictionTHIS CONSULTING AGREEMENT (the “Agreement”) is made and entered into as of May 16, 2023 (the “Effective Date”) by and between Mark Smith, with an address of [***] (“Consultant”), and Finch Therapeutics, Inc., a Delaware corporation with an address at 200 Inner Belt Road, Suite 400, Somerville, MA 02143 (“Finch”). Finch desires to obtain from Consultant various services, and Consultant desires to provide the services to Finch, all as provided in this Agreement. Each of Consultant and Finch may be referred to herein individually as a “Party,” or collectively as the “Parties”.
CONSULTING AGREEMENTConsulting Agreement • April 25th, 2023 • Finch Therapeutics Group, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledApril 25th, 2023 Company Industry JurisdictionTHIS CONSULTING AGREEMENT (the “Agreement”) is made and entered into as of April 21, 2023 (the “Effective Date”) by and between Matthew Blischak, with an address of [***] (“Consultant”), and Finch Therapeutics, Inc., a Delaware corporation with an address at 200 Inner Belt Road, Suite 400, Somerville, MA 02143 (“Finch”). Finch desires to obtain from Consultant various services, and Consultant desires to provide the services to Finch, all as provided in this Agreement. Each of Consultant and Finch may be referred to herein individually as a “Party,” or collectively as the “Parties”.